An International Wealth-Builder
This building-materials firm has pricing power despite a weak economy.
This building-materials firm has pricing power despite a weak economy.
The following alert was sent out July 9 notifying subscribers to Morningstar's InternationalInvestor newsletter that I had just bought shares of CRH for the newsletter's real money Passport Portfolio. This is just one example of the investment opportunities overseas. For more international picks, try a subscription to InternationalInvestor.
CRH is a diversified building-materials group headquartered in Ireland but operating worldwide. It is number one in concrete products, asphalt, and architectural glass in the United States, and it is also a large supplier of construction accessories, aggregates, and readymix concrete in the U.S. In Western Europe, it is number one in concrete products and construction accessories. It is growing rapidly in Eastern Europe, where it is now number one in building materials in Poland, number one in cement in Turkey, number three in cement in Poland and Tunisia, and number one in paving products in Slovakia. It also owns a series of DIY (do-it-yourself) stores in the Benelux countries. With the slowdown in the U.S., Ireland, the U.K., and Spain and growth in Eastern Europe, its sales are about 40% in the U.S., 40% in Western Europe, and 20% in Eastern Europe. By product, about 55% of sales are materials, 20% are concrete products, 13% distribution, and 12% other products.
I view CRH as kind of a cross between Cemex (CX), Vulcan Materials (VMC), and Home Depot (HD). Like Cemex and Vulcan Materials, CRH has been able to raise prices while volumes have decreased, which helps to maintain sales and margins. Although I expect profits to decline in 2008--for the first time in 16 years, I think the firm is continuing to strengthen its long-term competitive position. It has been steadily growing through acquisitions, and it has the balance sheet to continue to make acquisitions through this slowdown. It is also buying back stock.
The stock is trading a bit below $25 versus our fair value estimate of $48 and Consider Buying price of $36. Please see below for other valuation comparisons.
CRH Valuation Ratio Comparisons | |||||
Stock | P/E | P/B | P/S | P/CF | Yield (%) |
CRH | 6.2 | 1.1 | 0.4 | 3.8 | 4.1 |
Cemex (CX) | 7.1 | 1.2 | 0.8 | 4.1 | 3.6 |
Vulcan Materials (VMC) | 12.2 | 1.6 | 1.7 | 8.0 | 3.3 |
Home Depot (HD) | 11.5 | 2.2 | 0.6 | 7.7 | 3.9 |
CRH pays a dividend twice per year, going ex-dividend in March and September with the March dividend being significantly larger than the September dividend.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.